Mutual of America Capital Management’s Abiomed Inc ABMD Stock Holding History

Mutual of America Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,307	Closed	-$1.55M	–	1624
2022 Q3	$1.55M	Buy	6,307 +82	+1%	+$22.1K	0.02%	940
2022 Q2	$1.54M	Buy	6,225 +139	+2%	+$37.5K	0.02%	966
2022 Q1	$2.02M	Buy	6,086 +69	+1%	+$21.2K	0.02%	957
2021 Q4	$2.16M	Buy	6,017 +53	+0.9%	+$17.9K	0.02%	949
2021 Q3	$1.94M	Buy	5,964 +49	+0.8%	+$16.6K	0.02%	963
2021 Q2	$1.85M	Buy	5,915 +88	+2%	+$27K	0.02%	998
2021 Q1	$1.86M	Buy	5,827 +218	+4%	+$69.8K	0.02%	983
2020 Q4	$1.82M	Sell	5,609 -1,125	-17%	-$311K	0.02%	945
2020 Q3	$1.87M	Sell	6,734 -231	-3%	-$66.5K	0.02%	855
2020 Q2	$1.68M	Sell	6,965 -272	-4%	-$54.6K	0.02%	894
2020 Q1	$1.05M	Sell	7,237 -403	-5%	-$66.9K	0.02%	966
2019 Q4	$1.3M	Sell	7,640 -171	-2%	-$31.7K	0.02%	1049
2019 Q3	$1.39M	Buy	7,811 +795	+11%	+$172K	0.02%	999
2019 Q2	$1.83M	Buy	7,016 +223	+3%	+$59.2K	0.03%	918
2019 Q1	$1.94M	Buy	6,793 +450	+7%	+$150K	0.03%	881
2018 Q4	$2.06M	Buy	6,343 +148	+2%	+$51.4K	0.03%	785
2018 Q3	$2.79M	Buy	6,195 +342	+6%	+$135K	0.04%	738
2018 Q2	$2.39M	Sell	5,853 -29,495	-83%	-$10.7M	0.04%	805
2018 Q1	$10.3M	Sell	35,348 -24,420	-41%	-$6.19M	0.16%	109
2017 Q4	$11.2M	Sell	59,768 -67	-0.1%	-$12.5K	0.17%	92
2017 Q3	$10.1M	Buy	59,835 +2,592	+5%	+$392K	0.17%	100
2017 Q2	$8.2M	Sell	57,243 -15	-0%	-$2.02K	0.14%	129
2017 Q1	$7.17M	Sell	57,258 -6,907	-11%	-$801K	0.13%	167
2016 Q4	$7.23M	Buy	64,165 +878	+1%	+$102K	0.14%	152
2016 Q3	$8.14M	Sell	63,287 -3,829	-6%	-$459K	0.16%	104
2016 Q2	$7.33M	Buy	67,116 +2,735	+4%	+$272K	0.16%	116
2016 Q1	$6.1M	Buy	64,381 +19,651	+44%	+$1.66M	0.14%	159
2015 Q4	$4.04M	Sell	44,730 -20,233	-31%	-$1.72M	0.09%	295
2015 Q3	$6.03M	Sell	64,963 -5,000	-7%	-$441K	0.14%	135
2015 Q2	$4.6M	Sell	69,963 -31,900	-31%	-$2.12M	0.1%	251
2015 Q1	$7.29M	Sell	101,863 -39,522	-28%	-$2.15M	0.16%	117
2014 Q4	$5.38M	Buy	141,385 +2,227	+2%	+$70.2K	0.12%	193
2014 Q3	$3.46M	Hold	139,158	–	–	0.08%	346
2014 Q2	$3.5M	Sell	139,158 -28,333	-17%	-$659K	0.08%	359
2014 Q1	$4.36M	Hold	167,491	–	–	0.11%	246
2013 Q4	$4.48M	Buy	167,491 +2,576	+2%	+$63.7K	0.11%	233
2013 Q3	$3.15M	Buy	164,915 +4,160	+3%	+$95.1K	0.09%	356
2013 Q2	$3.47M	Buy	+160,755	New	+$3.23M	0.1%	254

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mutual of America Capital Management's ABMD Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,307 shares — an estimated $1.55M sold.

Mutual of America Capital Management first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $11.2M in Q4 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Mutual of America Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Mutual of America Capital Management sold 6,307 Abiomed Inc shares in Q4 2022, an estimated $1.55M.
Mutual of America Capital Management first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Mutual of America Capital Management's Abiomed Inc position peaked at $11.2M in Q4 2017.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.